Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Fabiola Atzeni; Piercarlo Sarzi-Puttini; Costantino Botsios; Antonio Carletto; Paola Cipriani; Ennio Giulio Favalli; Elena Frati; Valentina Foschi; Stefania Gasparini; Annarita Giardina; Elisa Gremese; Florenzo Iannone; Marco Sebastiani; Tamara Ziglioli; Domenico Biasi; Clodoveo Ferri; Mauro Galeazzi; Roberto Gerli; Roberto Giacomelli; Roberto Gorla; Marcello Govoni; Giovanni Lapadula; Antonio Marchesoni; Fausto Salaffi; Leonardo Punzi; Giovanni Triolo; Gianfranco Ferraccioli

doi:10.1016/j.autrev.2012.06.008

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Fabiola Atzeni
, Piercarlo Sarzi-Puttini
, Costantino Botsios
, Antonio Carletto
, Paola Cipriani
, Ennio Giulio Favalli
, Elena Frati
, Valentina Foschi
, Stefania Gasparini
, Annarita Giardina
, Elisa Gremese
, Florenzo Iannone
, Marco Sebastiani
, Tamara Ziglioli
, Domenico Biasi
, Clodoveo Ferri
, Mauro Galeazzi
, Roberto Gerli
, Roberto Giacomelli
, Roberto Gorla

Marcello Govoni, Giovanni Lapadula, Antonio Marchesoni, Fausto Salaffi, Leonardo Punzi, Giovanni Triolo, Gianfranco Ferraccioli

University of Milan
University of Padua
University of Verona
University of L'Aquila
Orthopedic Institute Gaetano Pini, Milan
University of Siena
University of Ferrara
Marche Polytechnic University
University of Palermo
University of Bari
University of Modena and Reggio Emilia
University of Brescia
University of Perugia

Research output: Contribution to journal › Article

112 Citations (Scopus)

Abstract

To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register.

Original language	English
Pages (from-to)	225-229
Number of pages	5
Journal	Autoimmunity Reviews
Volume	12
DOIs	https://doi.org/10.1016/j.autrev.2012.06.008
Publication status	Published - 2012

Keywords

anti-TNF therapy
rheumatoid arthritis

Access to Document

10.1016/j.autrev.2012.06.008

Cite this

Atzeni, F., Sarzi-Puttini, P., Botsios, C., Carletto, A., Cipriani, P., Favalli, E. G., Frati, E., Foschi, V., Gasparini, S., Giardina, A., Gremese, E., Iannone, F., Sebastiani, M., Ziglioli, T., Biasi, D., Ferri, C., Galeazzi, M., Gerli, R., Giacomelli, R., ... Ferraccioli, G. (2012). Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry. Autoimmunity Reviews, 12, 225-229. https://doi.org/10.1016/j.autrev.2012.06.008

@article{537af76f20054a55a37f81be91770622,

title = "Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry",

abstract = "To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register.",

keywords = "anti-TNF therapy, rheumatoid arthritis, anti-TNF therapy, rheumatoid arthritis",

author = "Fabiola Atzeni and Piercarlo Sarzi-Puttini and Costantino Botsios and Antonio Carletto and Paola Cipriani and Favalli, \{Ennio Giulio\} and Elena Frati and Valentina Foschi and Stefania Gasparini and Annarita Giardina and Elisa Gremese and Florenzo Iannone and Marco Sebastiani and Tamara Ziglioli and Domenico Biasi and Clodoveo Ferri and Mauro Galeazzi and Roberto Gerli and Roberto Giacomelli and Roberto Gorla and Marcello Govoni and Giovanni Lapadula and Antonio Marchesoni and Fausto Salaffi and Leonardo Punzi and Giovanni Triolo and Gianfranco Ferraccioli",

year = "2012",

doi = "10.1016/j.autrev.2012.06.008",

language = "English",

volume = "12",

pages = "225--229",

journal = "Autoimmunity Reviews",

issn = "1568-9972",

publisher = "Elsevier BV",

}

Atzeni, F, Sarzi-Puttini, P, Botsios, C, Carletto, A, Cipriani, P, Favalli, EG, Frati, E, Foschi, V, Gasparini, S, Giardina, A, Gremese, E, Iannone, F, Sebastiani, M, Ziglioli, T, Biasi, D, Ferri, C, Galeazzi, M, Gerli, R, Giacomelli, R, Gorla, R, Govoni, M, Lapadula, G, Marchesoni, A, Salaffi, F, Punzi, L, Triolo, G & Ferraccioli, G 2012, 'Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry', Autoimmunity Reviews, vol. 12, pp. 225-229. https://doi.org/10.1016/j.autrev.2012.06.008

TY - JOUR

T1 - Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

AU - Atzeni, Fabiola

AU - Sarzi-Puttini, Piercarlo

AU - Botsios, Costantino

AU - Carletto, Antonio

AU - Cipriani, Paola

AU - Favalli, Ennio Giulio

AU - Frati, Elena

AU - Foschi, Valentina

AU - Gasparini, Stefania

AU - Giardina, Annarita

AU - Gremese, Elisa

AU - Iannone, Florenzo

AU - Sebastiani, Marco

AU - Ziglioli, Tamara

AU - Biasi, Domenico

AU - Ferri, Clodoveo

AU - Galeazzi, Mauro

AU - Gerli, Roberto

AU - Giacomelli, Roberto

AU - Gorla, Roberto

AU - Govoni, Marcello

AU - Lapadula, Giovanni

AU - Marchesoni, Antonio

AU - Salaffi, Fausto

AU - Punzi, Leonardo

AU - Triolo, Giovanni

AU - Ferraccioli, Gianfranco

PY - 2012

Y1 - 2012

N2 - To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register.

AB - To evaluate the risk of serious infections (SIs) in RA patients receiving anti-TNF therapy on the basis of the data included in the GISEA register.

KW - anti-TNF therapy

KW - rheumatoid arthritis

KW - anti-TNF therapy

KW - rheumatoid arthritis

UR - http://hdl.handle.net/10807/41251

U2 - 10.1016/j.autrev.2012.06.008

DO - 10.1016/j.autrev.2012.06.008

M3 - Article

SN - 1568-9972

VL - 12

SP - 225

EP - 229

JO - Autoimmunity Reviews

JF - Autoimmunity Reviews

ER -

Long-term anti-TNF therapy and the risk of serious infections in a cohort of patients with rheumatoid arthritis: comparison of adalimumab, etanercept and infliximab in the GISEA registry

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this